I think there was a time where the largest buyer here, Jason Carrol, was unknown. Looks like he has emerged as TYP (listed today) CEO and third largest holder over there.
Also out of interest as well, Bill Garner and Peter Molloy, both, ex-RAC, Bill being second biggest holder at TYP, and I believe may still be invested here?
Not cross promoting or suggesting TYP is good, but interesting nonetheless that every person and company mentioned have one shared link between them.
I agree this company could be capped 10x higher and for it to still be reasonable, but there is two or three main reasons it isn't. 1. Had to perform dose escalation before PEACH which wasn't expected, 2. Remuneration report was rejected - market has no faith in management, 3. Poor communication.
This company could be a game changer, just a lot of patience needed.
Ann: Grant funding to directly support Phase 2a trial, page-41
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.015(7.89%) |
Mkt cap ! $26.97M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 16.5¢ | $103.4K | 595.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 65512 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| ILA (ASX) Chart |